Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giunti Psychometrics Holding SpAFRA:0ZD 16 EBITDA Margin % is 17.20% as of Dec. 2025, which is 6% above its 10-year median of 16.18. GuruFocus rates FRA:0ZD with a GF Score™ of 16/100. Among 815 Medical Devices & Instruments companies, Giunti Psychometrics Holding SpA ranks better than 69.2% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Giunti Psychometrics Holding SpA EBITDA Margin % Related Terms
Giunti Psychometrics Holding SpA EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0ZD vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giunti Psychometrics Holding SpA EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Giunti Psychometrics Holding SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giunti Psychometrics Holding SpA (FRA:0ZD) has a EBITDA Margin % of 17.20% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Giunti Psychometrics Holding SpA and its competitors. This is near median its historical median of 16.18. Over the past decade, Giunti Psychometrics Holding SpA's EBITDA Margin % has ranged from 15.15 to 17.20. According to the industry distribution chart, Giunti Psychometrics Holding SpA ranks #251 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 30.8%.
Is Giunti Psychometrics Holding SpA's EBITDA Margin % too high?
Giunti Psychometrics Holding SpA's current EBITDA Margin % of 17.20% is near median its 10-year median of 16.18. Over the past 10 years, this metric has ranged from a low of 15.15 to a high of 17.20. The Medical Devices & Instruments industry median EBITDA Margin % is 7.86. Giunti Psychometrics Holding SpA's value of 17.20% is 118.8% above this industry median. Based on the distribution chart, Giunti Psychometrics Holding SpA ranks #251 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Giunti Psychometrics Holding SpA ranks #251 out of 815 companies for EBITDA Margin %. This puts Giunti Psychometrics Holding SpA in the upper half of its industry. The industry median EBITDA Margin % is 7.86. Giunti Psychometrics Holding SpA's value of 17.20% is 118.8% above this benchmark. Historically, Giunti Psychometrics Holding SpA's own EBITDA Margin % has ranged from 15.15 to 17.20 over the past decade. While the company's 10-year median is 16.18 vs. the industry median of 7.86, Giunti Psychometrics Holding SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giunti Psychometrics Holding SpA's current EBITDA Margin % of 17.20% is 118.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Giunti Psychometrics Holding SpA and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giunti Psychometrics Holding SpA's current EBITDA Margin % is 17.20%, which is near median its own 10-year median of 16.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (FRA:0ZD) has a current EBITDA Margin % of 17.20%. The current EBITDA Margin % is 17.20%, which is near median its 10-year median of 16.18 and 118.8% above the Medical Devices & Instruments industry median of 7.86. Giunti Psychometrics Holding SpA's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (FRA:0ZD), the current EBITDA Margin % is 17.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
16GF Score
Get the complete analysis for FRA:0ZD
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0ZD has been successfully added to your 
